JATHEME

Welcome to the Brand page for “JATHEME”, which is offered here for Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, renal failure, anoxia-induced cellular degeneration, and hypoxia-induced cellular degeneration;.

Its status is currently believed to be active. Its class is unavailable. “JATHEME” is believed to be currently owned by “Affymax Pharma Limited”.